title: Neoral: the new cyclosporine.
abstract: Neoral is an improved formulation of cyclosporine which, through microemulsion technology, provides a more consistent rate of absorption and exposure. If patients are able to take less Neoral and still maintain the same cyclosporine level, there will also be a cost savings involved. A dose reduction of 30% yields pharmacoeconomic savings. With a more consistent rate of absorption, the risks of nephrotoxicity may be reduced.
authors.affiliation: University of Utah, Salt Lake City, USA.
authors.forename: J
authors.initials: J
authors.lastname: Corbett
authors.forename: K
authors.initials: K
authors.lastname: Ross
mesh_terms: D000284:Administration, Oral; D002214:Capsules; D002626:Chemistry, Pharmaceutical; D016572:Cyclosporine / Q000737:chemistry / Q000627:therapeutic use*; D004655:Emulsions; D006801:Humans; D007166:Immunosuppressive Agents / Q000737:chemistry / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D014181:Transplantation Immunology
chemical_list: D002214:Capsules; D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine